TIL Cells for the Treatment of the Advanced Solid Tumors Patients

NCT05649618 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

UNKNOWN

Status

42

Enrollment

OTHER_GOV

Sponsor class

Conditions

Solid Tumor

Interventions

BIOLOGICAL: Tumor Infiltrating Lymphocytes
DRUG: Fludarabine
DRUG: Cyclophosphamide Capsules
DRUG: IL-2

Sponsor

Fujian Cancer Hospital